about
Genome microevolution of chikungunya viruses causing the Indian Ocean outbreakFiber mediated receptor masking in non-infected bystander cells restricts adenovirus cell killing effect but promotes adenovirus host co-existenceGene delivery from replication-selective viruses: arming guided missiles in the war against cancer.Immunomodulation of cancer: potential use of selectively replicating agents.Regulatable systems: applications in gene therapy and replicating viruses.Oncolytic viruses: From bench to bedside with a focus on safety.Clinical research results with dl1520 (Onyx-015), a replication-selective adenovirus for the treatment of cancer: what have we learned?Replication-selective oncolytic adenoviruses: virotherapy aimed at genetic targets in cancer.Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancerLess is more, regularly: metronomic dosing of cytotoxic drugs can target tumor angiogenesis in miceOncolytic virotherapy for cancer with the adenovirus dl1520 (Onyx-015): results of phase I and II trials.Gene therapy for high grade gliomas.MicroRNA-mediated suppression of oncolytic adenovirus replication in human liverClinical development of experimental therapies for malignant glioma.Chapter One---Cancer terminator viruses and approaches for enhancing therapeutic outcomes.pH-sensitive oncolytic adenovirus hybrid targeting acidic tumor microenvironment and angiogenesisGene therapy of benign gynecological diseases.Tissue-specific promoters for cancer gene therapy.Activation of Cyclic Adenosine Monophosphate Pathway Increases the Sensitivity of Cancer Cells to the Oncolytic Virus M1A promoter region of the midkine gene that is frequently expressed in human hepatocellular carcinoma can activate a suicide gene as effectively as the alpha-fetoprotein promoter.Enhanced antitumor efficacy of a herpes simplex virus mutant isolated by genetic selection in cancer cellsTherapeutic efficacy of an oncolytic adenovirus containing RGD ligand in minor capsid protein IX and Fiber, Δ24DoubleRGD, in an ovarian cancer modelSelectivity of a replication-competent adenovirus for human breast carcinoma cells expressing the MUC1 antigen.Adenoviral Vectors Armed with Cell Fusion-Inducing Proteins as Anti-Cancer Agents.An overview of gene therapy in head and neck cancer.Oncoapoptotic markers in oral cancer: prognostics and therapeutic perspective.Mesenchymal stromal cells for the delivery of oncolytic viruses in gliomas.Local sustained delivery of oncolytic adenovirus with injectable alginate gel for cancer virotherapy.Oncolytic adenovirus armed with human papillomavirus E2 gene in combination with radiation demonstrates synergistic enhancements of antitumor efficacy.Inhibition of renal cancer cell growth in vitro and in vivo with oncolytic adenovirus armed short hairpin RNA targeting Ki-67 encoding mRNA.Conditionally replicating E1B-deleted adenovirus driven by the squamous cell carcinoma antigen 2 promoter for uterine cervical cancer therapy.p53-expressing conditionally replicative adenovirus CNHK500-p53 against hepatocellular carcinoma in vitro.Oncolytic adenovirus-mediated transfer of the antisense chk2 selectively inhibits tumor growth in vitro and in vivo.Pilot trial of intravenous infusion of a replication-selective adenovirus (ONYX-015) in combination with chemotherapy or IL-2 treatment in refractory cancer patients.Intra-arterial administration of a replication-selective adenovirus (dl1520) in patients with colorectal carcinoma metastatic to the liver: a phase I trial.An armed oncolytic adenovirus system, ZD55-gene, demonstrating potent antitumoral efficacy.Intravenous infusion of a replication-selective adenovirus (ONYX-015) in cancer patients: safety, feasibility and biological activity.Conditionally replicative adenovirus expressing a targeting adapter molecule exhibits enhanced oncolytic potency on CAR-deficient tumors.Transcriptional targeting of conditionally replicating adenovirus to dividing endothelial cells.Intravascular injections of a conditional replicative adenovirus (adl118) prevent metastatic disease in human breast carcinoma xenografts.
P2860
Q21144706-8D1587AE-5E4C-4DBC-A7F9-8144735113B7Q33521271-232FDD3E-1767-4982-BB82-DFA944CAA7E3Q33904270-2D538F1F-C393-46C8-B27F-A2F0B9DA6860Q33904276-E814FC79-107C-41EB-B7CF-C1F8612CE5E4Q33904282-E6F1228E-C14F-429D-9FFE-CAEB876A2F18Q34044071-8D19192F-D498-4010-9586-A80A7F1EAB5EQ34225918-AD63FBEA-5FD8-44ED-9664-CDE1CA8BF779Q34293607-ABB814EF-5C74-4C71-80D2-969363142BE5Q34327051-0C1C4603-A676-4A19-B9A8-59E0836D7BD9Q34432972-E9ADC07C-3CE3-4907-885D-CC3077C654DDQ34452020-9DB940CE-B0D5-4BE7-BFF3-5068CBED17D5Q34452062-2A3A53C7-D218-4028-8ADC-296AB364C892Q34563212-E560620A-AB95-4D66-B1A3-398DFCBE22ECQ34782295-A507FC2E-7A6D-45A6-B7D4-7B8D1B1F39AFQ35142325-AB78CD05-02C8-4474-A52F-19BEE390918BQ35569909-CB4529B3-5FC9-4140-B7C3-30B9565CD023Q35770271-175240F2-5D26-4B0C-AE13-72255077EADDQ35779378-F4E3EBAC-99C1-4B45-979B-0E028A0E2C71Q36582828-87CACEBB-B84B-4B5B-AF14-8A79ACD48068Q36648397-A920ECAA-1138-40E8-99F9-AC9B4414B6C1Q37116149-DC9F1817-BD4C-4D16-99DD-69E3B2FBD2F5Q37127836-8609444A-0E99-43FF-984D-A00E789B27B6Q37269915-493E94D6-B667-4AB7-933F-18112D470876Q37628219-7B9DE842-B7CC-4520-B000-0C1B818C216AQ38171470-38202FC1-FD65-40B7-A025-B6748C954387Q38212609-CB626A8B-C79E-4391-811B-0813F65F8329Q38715077-23CA956D-D6DC-4881-A6BE-6DDD3A76B626Q39178068-0E83B0A9-AD01-4B29-B38E-24A5926AF6E0Q39488257-B60E5366-D5C3-43BA-83A5-4C1F342CBCA0Q39952467-51BDEDA7-A4EC-4330-ABE7-857DAD7E592EQ39979621-50C9E2CB-21A9-481C-AE32-5D78D3C0BB28Q40174557-F6EFD77B-0994-45F1-8CDD-7CB2CAD94226Q40272352-89D10DD1-7EA6-48B1-8F78-45CF85DAD199Q40560199-D7D990AF-3DDB-4B90-A421-E9902315E117Q40586745-30BB913F-3501-4CF2-8E8A-818D8250A27CQ40598664-D7AFC056-C7B2-4F74-B04D-58396C673A58Q40601029-B48D0000-AD8A-4C3C-887B-35023D904A19Q40628834-7F7F7EE5-DF9F-401C-B8AF-7184EBDEAF68Q40722083-34054A3A-190C-43D5-AC86-04205CCFFFC1Q40744683-96723000-21E7-4015-85CF-1713F64FD6B7
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Replication-selective adenoviruses as oncolytic agents.
@ast
Replication-selective adenoviruses as oncolytic agents.
@en
type
label
Replication-selective adenoviruses as oncolytic agents.
@ast
Replication-selective adenoviruses as oncolytic agents.
@en
prefLabel
Replication-selective adenoviruses as oncolytic agents.
@ast
Replication-selective adenoviruses as oncolytic agents.
@en
P2860
P356
P1476
Replication-selective adenoviruses as oncolytic agents.
@en
P2093
P2860
P304
P356
10.1172/JCI9762
P407
P577
2000-04-01T00:00:00Z